Found 40 matching trials
Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion
PHASE4Central retinal vein occlusion (CRVO) is a common retinal vascular disorder...
Location
Multiple Locations
The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
PHASE4A study investigating the ability of OCTA imaging technology to identify an...
Location
Stein Eye Institute of UCLA
Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis Study
NAAge-related macular degeneration (AMD) is a leading cause of visual impairm...
Location
Unit of Clinical Nutrition, University Hospital of Careggi
PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept
PHASE4The presence of PEDs in nAMD, CSR and iPCV can present a diagnostic challen...
Location
Sunnybrook Research Institute
Zhuochuming®-3T&E-DME Study (Treatment-naïve Patients)
PHASE4The goal of this clinical trial is to understand whether Zhuochuming® (Afli...
Location
The Third Peoples Hospital of Dalian
A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
PHASE4This is a randomized, masked, active-controlled, parallel-group, multi-cent...
Status
Active Not Recruiting
Location
Investigative Site
A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
PHASE3This was a Phase III, randomized, double-masked, multi-center, active-contr...
Location
Novartis Investigative Site
A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
PHASE3This is a randomised, double-masked, parallel group, multicentre study to e...
Location
SB Investigative Site
Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.
EARLY_PHASE1Comparison of efficacy and safety of Mitomycin and Aflibercept used to supp...
Location
Medical University of Lublin
Switching to Faricimab in Neovascular Age-related Macular Degeneration Resistant to Both Aflibercept and Ranibizumab
N/AThe goal of this retrospective single-center chart review is to establish t...